Consistent with this, Ji et al. reported that the expression of METTL3 was significantly lower in glioma tumor tissues than in adjacent normal tissues, and this downregulation mediated GBM occurrence by altering the PI3K/Akt pathway [53]. The gene discussed is METTL3; the disease is glioma.